Molecular Partners AG

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MOLN and other ETFs, options, and stocks.

About MOLN

Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. 

CEO
Patrick Amstutz
CEOPatrick Amstutz
Employees
174
Employees174
Headquarters
Schlieren, Zurich
HeadquartersSchlieren, Zurich
Founded
2004
Founded2004
Employees
174
Employees174

MOLN Key Statistics

Market cap
162.72M
Market cap162.72M
Price-Earnings ratio
-2.14
Price-Earnings ratio-2.14
Dividend yield
Dividend yield
Average volume
5.07K
Average volume5.07K
High today
$4.29
High today$4.29
Low today
$4.00
Low today$4.00
Open price
$4.00
Open price$4.00
Volume
6.40K
Volume6.40K
52 Week high
$5.41
52 Week high$5.41
52 Week low
$3.36
52 Week low$3.36

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.